In particular, the mRNA expression of VPS26A was significantly related to the levels of KRAS, and TP53 mutations (Figure 2F,G), and correlated with the genetic status (deletion or amplification) of VPS26A in PAAD (Figure 2D). The gene discussed is VPS26A; the disease is pancreatic adenocarcinoma.